ProSomnus Sleep Technologies has been selected to present at the Digital Medicine and MedTech Showcase, Jan 7-9, 2019, in San Francisco. This annual event is a forum that connects leaders in medicine with companies that are developing novel technologies to address important healthcare issues.

In a release, ProSomnus states it will utilize the opportunity to raise awareness of obstructive sleep apnea (OSA) and how the company is using technology to enable better therapy.

“Obstructive sleep apnea is a large, rapidly growing, public health issue that is largely unaddressed,” says Len Liptak, CEO and co-founder of ProSomnus Sleep Technologies, in a release. “To scale this issue, OSA therapies need to be effective for everyday use, easy to prescribe, and economical. ProSomnus sleep devices are designed to help patients and providers achieve these goals.”

ProSomnus will discuss how digital manufacturing technologies are utilized to produce precision medical devices that are customized to the anatomy and prescription for each and every patient.

“OSA is a medical condition, diagnosed by a medical doctor, where dentists are the DME [durable medical equipment] provider. ProSomnus devices enable the type of predictable performance that is expected by every member of the treatment team,” says Mark T. Murphy, DDS, lead faculty for ProSomnus.

Edward T. Sall, MD, DDS, MBA, medical director for ProSomnus, says, “Obstructive sleep apnea is a lifelong disease with serious comorbidities that is under diagnosed and grossly under treated. In the past, the primary form of treatment was CPAP, which is highly efficacious but its effectiveness is compromised by poor compliance. ProSomnus oral appliances are highly effective in the treatment of OSA due to their high compliance in patients. Since OSA is a lifelong disease, treatment with the ProSomnus oral appliance represents a paradigm shift to a global problem of over 1 billion people with OSA.”